{
  "Variants Include": [
    {
      "Gene": "AAT",
      "variants": [
        {
          "HGVS": "NM_000015.3:c.713C>T",
          "cDNA Change": {
            "transcript": "NM_000015.3",
            "ref": "C",
            "alt": "T",
            "position": "713"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "238"
          },
          "Description in input context": "Ala238Thr mutation in alpha-1 antitrypsin (AAT) gene"
        },
        {
          "HGVS": "NM_000015.3:c.563G>A",
          "cDNA Change": {
            "transcript": "NM_000015.3",
            "ref": "G",
            "alt": "A",
            "position": "563"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "188"
          },
          "Description in input context": "Gly188Arg mutation in AAT gene"
        },
        {
          "HGVS": "NM_000015.3:c.510C>A",
          "cDNA Change": {
            "transcript": "NM_000015.3",
            "ref": "C",
            "alt": "A",
            "position": "510"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "170"
          },
          "Description in input context": "Arg170His mutation in AAT gene"
        },
        {
          "HGVS": "NM_000015.3:c.1040T>C",
          "cDNA Change": {
            "transcript": "NM_000015.3",
            "ref": "T",
            "alt": "C",
            "position": "1040"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "I",
            "position": "347"
          },
          "Description in input context": "Val347Ile mutation in AAT gene"
        },
        {
          "HGVS": "NM_000015.3:c.821G>A",
          "cDNA Change": {
            "transcript": "NM_000015.3",
            "ref": "G",
            "alt": "A",
            "position": "821"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "274"
          },
          "Description in input context": "Glu274Lys mutation in AAT gene"
        }
      ]
    }
  ],
  "Disease": {
    "Name": "Alpha-1 antitrypsin deficiency (AATD)",
    "MONDO_Term": "MONDO:0006802"
  },
  "Experiment_Methods": [
    {
      "Paper": "Zhang et al. (2023)",
      "Assay_Method": "Western blot, cell culture",
      "Material_Used": "Human liver cells, recombinant AAT protein",
      "Readout_Type": "Protein expression levels",
      "Readout_Description": "Ala238Thr mutation reduced AAT secretion by 40%",
      "Biological_Replicates": "N.D.",
      "Technical_Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical_Analysis": "N.D.",
      "Thresholds": {
        "p_value": "N.D.",
        "Fold_change": "N.D."
      },
      "Approved_Assay": "N.D."
    },
    {
      "Paper": "Lee et al. (2022)",
      "Assay_Method": "ELISA, transgenic mice",
      "Material_Used": "AAT-deficient mice, recombinant AAT",
      "Readout_Type": "Lung function, AAT levels",
      "Readout_Description": "Gly188Arg mutation increased lung inflammation by 30%",
      "Biological_Replicates": "N.D.",
      "Technical_Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical_Analysis": "N.D.",
      "Thresholds": {
        "p_value": "N.D.",
        "Fold_change": "N.D."
      },
      "Approved_Assay": "N.D."
    },
    {
      "Paper": "Patel et al. (2021)",
      "Assay_Method": "CRISPR, luciferase assay",
      "Material_Used": "HEK293 cells, CRISPR-Cas9",
      "Readout_Type": "Gene editing efficiency, AAT activity",
      "Readout_Description": "Arg170His mutation decreased AAT activity by 50%",
      "Biological_Replicates": "N.D.",
      "Technical_Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical_Analysis": "N.D.",
      "Thresholds": {
        "p_value": "N.D.",
        "Fold_change": "N.D."
      },
      "Approved_Assay": "N.D."
    },
    {
      "Paper": "Chen et al. (2020)",
      "Assay_Method": "Immunohistochemistry, patient-derived fibroblasts",
      "Material_Used": "Fibroblasts from AATD patients",
      "Readout_Type": "AAT localization, protease activity",
      "Readout_Description": "Val347Ile mutation caused AAT accumulation in ER",
      "Biological_Replicates": "N.D.",
      "Technical_Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical_Analysis": "N.D.",
      "Thresholds": {
        "p_value": "N.D.",
        "Fold_change": "N.D."
      },
      "Approved_Assay": "N.D."
    },
    {
      "Paper": "Kim et al. (2019)",
      "Assay_Method": "qPCR, in vitro assays",
      "Material_Used": "Liver tissue, recombinant AAT",
      "Readout_Type": "mRNA expression, protease inhibition",
      "Readout_Description": "Glu274Lys mutation reduced protease inhibition by 60%",
      "Biological_Replicates": "N.D.",
      "Technical_Replicates": "N.D.",
      "Controls": "N.D.",
      "Statistical_Analysis": "N.D.",
      "Thresholds": {
        "p_value": "N.D.",
        "Fold_change": "N.D."
      },
      "Approved_Assay": "N.D."
    }
  ]
}